Literature DB >> 3908182

Suppression of B cell development and antibody responses in mice with polyclonal rabbit and monoclonal rat anti-IgM antibodies. I. Characterization of the suppressed state.

A Cerny, A W Hügin, S Sutter, C H Heusser, N Bos, S Izui, H Hengartner, R M Zinkernagel.   

Abstract

Mice treated from birth with polyclonal, crude or affinity purified rabbit or monoclonal rat anti-mouse IgM antibodies [b-7-6 and C-2-23: Eur. J. Immunol. 14: 753-757, 1984] were found to be heavily suppressed with respect to B-cell activities. Crude or affinity purified rabbit or monoclonal rat anti-mouse IgM gave comparable results as follows: serum IgM was below detectable levels; serum IgG was reduced to about 1-3% of normal levels; free anti-IgM was always detectable; IgM and/or kappa-light-chain positive cells as well as IgM-secreting cells were absent in various lymphoid organs; the B-cell mitogen lipopolysaccharide was unable to induce proliferative responses; primary antibody responses could not be induced against sheep red blood cells and phosphorylcholine; lymphoid organs were reduced in size and B-cell areas were not populated with lymphocytes; besides a 40% reduction in absolute lymphocyte numbers in the blood, we found increased platelet counts and a 10% eosinophilia in anti-IgM-treated mice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908182     DOI: 10.1159/000163327

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  9 in total

1.  Anti-IgM treatment of C57BL/6-1pr/1pr mice: depletion of B cells reduces 1pr gene-induced lymphoproliferation and mononuclear cell vasculitis.

Authors:  A Cerny; M Kimoto; A W Hügin; R Merino; S Izui
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Pathogenesis of Aleutian mink disease parvovirus infection: effects of suppression of antibody response on viral mRNA levels and on development of acute disease.

Authors:  S Alexandersen; T Storgaard; N Kamstrup; B Aasted; D D Porter
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.

Authors:  U Dahmen; H Sun; Y Li; F Fu; A J Demetris; T E Starzl; S Qian; J J Fung
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

4.  Development of follicular dendritic cells in lymph nodes of B-cell-depleted mice.

Authors:  A Cerny; R M Zinkernagel; P Groscurth
Journal:  Cell Tissue Res       Date:  1988-11       Impact factor: 5.249

5.  Anti-Listeria monocytogenes immunity in mu-suppressed mice: a comparison of treatment with conventional hyperimmune rabbit anti-mouse IgM and affinity-purified, monoclonal rat anti-mouse IgM.

Authors:  A Cerny; A W Hügin; H Bazin; S Sutter; H Hengartner; R M Zinkernagel
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

6.  Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice.

Authors:  A Cerny; S Sutter; H Bazin; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  An immunoglobulin C kappa-reactive single chain antibody fusion protein induces tolerance through receptor editing in a normal polyclonal immune system.

Authors:  Djemel Ait-Azzouzene; Laurent Verkoczy; Jorieke Peters; Amanda Gavin; Patrick Skog; José Luis Vela; David Nemazee
Journal:  J Exp Med       Date:  2005-02-28       Impact factor: 14.307

8.  B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome.

Authors:  A Cerny; A W Hügin; R R Hardy; K Hayakawa; R M Zinkernagel; M Makino; H C Morse
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay?

Authors:  R M Zinkernagel; E Haenseler; T Leist; A Cerny; H Hengartner; A Althage
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.